The aim of our present study was to estimate serum insulin, insulin-like growth factor-1, testosterone and lipid levels in benign prostatic hyperplasia, prostate cancer and control group and establish their association with risk of benign prostatic hyperplasia and prostate cancer and its severity at the time of diagnosis. The gene discussed is INS; the disease is prostate cancer.